Michael Shapiro, MD
Vascular Surgery · Brooklyn, NYNPI 1184888968
Payments from drug & device makers
What this record shows
This record is dominated by other: $52,250 of the $54,409 with a category attached, or 96.0%. Angiodynamics, Inc. accounts for 96.2% of it on its own, with 12 other manufacturers making up the rest.
Across 49 payments — averaging $1110.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$52K
- W. L. Gore & Associates, Inc.$481
- Medtronic$393
- Terumo Medical Corporation$306
- Cvrx, Inc.$248
- Abbott$203
- plus $456 from 7 others
What the payments were for
- Travel & lodging$1270%
- Food & beverage$2,0324%
- Other$52,25096%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 9 | $52,323 |
| W. L. Gore & Associates, Inc. | 4 | $481 |
| Medtronic | 7 | $393 |
| Terumo Medical Corporation | 6 | $306 |
| Cvrx, Inc. | 3 | $248 |
| Abbott | 11 | $203 |
| Boston Scientific | 1 | $166 |
| Endologix LLC | 2 | $152 |
| Shockwave Medical, Inc | 1 | $46 |
| Globus Medical | 2 | $40 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Penumbra, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$52,250
- VIABAHN VBX Balloon Expandable Endoprosthesis$344
- HawkOne$285
- TR Band$209
- Barostim Neo System$136
- AFX$112
- Navicross$101
- ANGIO-SEAL$101
- GLIDESHEATH SLENDER$101
- GlideWire$101
How this compares
$54,409 in reported general payments places this provider in the 85th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 116 | $1,151 |
| Tramadol Hcl | 180 | $244 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Brooklyn
- Robert RheeBrooklyn$338K
- Nicole IlonzoBrooklyn$94K
- William LoisBrooklyn$39K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.5M
- Sonya NoorBuffalo$991K
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.